Dr. Julie Sommer

 

Post-doctoral Fellow

DNAX
Palo Alto, California

julie.sommer@DNAX.org

(Dr. Paul Bertics, Advisor at UW Madison)

Info:

Julie now works at DNAX (a research institute/biotech company that is owned by Schering-Plough) in Palo Alto, CA as a post-doctoral fellow.

Research Interests:

She is conducting research in signal transdution, cancer and inflammatory diseases.

Recent Publications:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=search&term=Sommer%2Bja

  • Aga M, Watters JJ, Pfeiffer ZA, Wiepz GJ, Sommer JA, and Bertics PJ. (2004). Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-kappa B signaling pathways in murine RAW 264.7 macrophages. Am J Physiol. 286:C923-30. PDF PMID 14684387

  • Guerra AN, Fisette PL, Pfeiffer ZA, Quinchia-Rios BH, Prabhu U, Aga M, Denlinger LC, Guadarrama AG, Abozeid S, Sommer JA, Proctor RA, and Bertics PJ. (2003). Purinergic receptor regulation of LPS-induced signaling and pathophysiology. J Endotox Res. 9:256-63. PMID 12935357

  • Watters JJ, Sommer JA, Pfeiffer ZA, Prabhu U, Guerra AN, and Bertics PJ. (2002). A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production. J Biol Chem. 277:9077-87. PDF PMID 11786532

  • Denlinger LC, Sommer JA, Parker K, Gudipaty L, Fisette PL, Watters JW, Proctor RA, Dubyak GR, and Bertics PJ. (2003). Mutation of a dibasic amino acid motif within the C terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function. J Immunol. 171:1304-11. PDF PMID 12874219

  • Denlinger LC, Fisette PL, Sommer JA, Watters JJ, Prabhu U, Dubyak GR, Proctor RA, and Bertics PJ. (2001). Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol. 167:1871-6. PDF PMID 11489964

  • Sommer JA, Fisette PL, Hu Y, Denlinger LC, Guerra AN, Bertics PJ, and Proctor RA. (1999). Purinergic receptor modulation of LPS-stimulated signaling events and nitric oxide release in RAW 264.7 macrophages. J Endotox Res. 5:70-74.

  • Denlinger LC, Garis KA, Sommer JA, Guadarrama AG, Proctor RA, and Bertics PJ. (1998). Nuclear translocation of NF-kappaB in lipopolysaccharide-treated macrophages fails to correspond to endotoxicity: evidence suggesting a requirement for a gamma interferon-like signal. Infection & Immunity. 66:1638-47. PDF PMID 9529092

  • Hu Y, Fisette PL, Denlinger LC, Guadarrama AG, Sommer JA, Proctor RA, and Bertics PJ. (1998). Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem. 273:27170-5. PDF PMID 9765236

[Back to Alumni] [Home]